Cwm, LLC Ptc Therapeutics, Inc. Transaction History

Cwm, LLC

$25.1 Billion
Q1 2025

A detailed history of Cwm, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 17,756 shares of PTCT stock, worth $918,517. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,756

Previous 3,617 390.9%

Holding current value

$918,517

Previous $163,000 455.21%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$41.81 - $57.17 $591,151 - $808,326	14,139 Added 390.9%	17,756 $905,000
Q4 2024 Feb 04, 2025	BUY	$34.99 - $52.07 $32,540 - $48,425	930 Added 34.61%	3,617 $163,000
Q3 2024 Oct 08, 2024	BUY	$30.39 - $37.66 $63,697 - $78,935	2,096 Added 354.65%	2,687 $100,000
Q2 2024 Jul 09, 2024	BUY	$24.69 - $40.12 $13,406 - $21,785	543 Added 1131.25%	591 $18,000
Q1 2024 Apr 05, 2024	BUY	$24.15 - $31.95 $338 - $447	14 Added 41.18%	48 $1,000
Q4 2023 Feb 01, 2024	SELL	$18.07 - $29.37 $1,825 - $2,966	-101 Reduced 74.81%	34 $1,000
Q3 2023 Oct 11, 2023	SELL	$22.41 - $41.99 $20,774 - $38,924	-927 Reduced 87.29%	135 $3,000
Q2 2023 Aug 03, 2023	BUY	$40.4 - $59.1 $3,434 - $5,023	85 Added 8.7%	1,062 $43,000
Q4 2022 Feb 01, 2023	BUY	$33.53 - $54.79 $32,289 - $52,762	963 Added 6878.57%	977 $37,000
Q2 2022 Jul 28, 2022	SELL	$25.6 - $45.23 $1,587 - $2,804	-62 Reduced 81.58%	14 $1,000
Q1 2022 Apr 21, 2022	SELL	$33.33 - $44.6 $566 - $758	-17 Reduced 18.28%	76 $3,000
Q4 2021 Jan 31, 2022	BUY	$35.36 - $41.86 $3,288 - $3,892	93 New	93 $4,000

Others Institutions Holding PTCT

# of Institutions

284

Shares Held

78.5M

Call Options Held

223K

Put Options Held

156K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.7B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account